APN

COM:ASPENPHARMA

Aspen Pharmacare

  • Stock

Last Close

17,025.00

22/11 15:04

Market Cap

1.03B

Beta: -

Volume Today

1.21M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Jun '14
Jun '15
Jun '16
Jun '17
Jun '18
Jun '19
Jun '20
Jun '21
Jun '22
Jun '23
Jun '24
net income
7.91B
-
8.45B
6.81%
9B
6.51%
8.30B
7.78%
9.24B
11.29%
5.06B
45.18%
7.42B
46.52%
6.64B
10.54%
8.67B
30.63%
7.82B
9.79%
7.00B
10.53%
depreciation and amortization
1.04B
-
1.20B
15.46%
1.30B
8.33%
1.37B
5.54%
1.27B
7.14%
1.60B
25.82%
1.65B
3.12%
1.71B
3.63%
1.79B
4.38%
1.97B
10.35%
deferred income tax
-2.94B
-
-3.30B
12.35%
-1.78B
-
1.14B
163.93%
-882M
177.50%
-1.75B
98.07%
-1.64B
6.35%
-435M
73.41%
stock based compensation
50.80M
-
100M
96.85%
43M
-
37M
13.95%
49M
32.43%
67M
36.73%
58M
13.43%
135M
132.76%
117M
13.33%
change in working capital
-2.19B
-
-1.47B
32.94%
-3.40B
131.78%
-900M
73.53%
-1.58B
75.44%
-1.38B
12.73%
192M
113.93%
648M
237.50%
-2.65B
509.26%
-3.36B
26.62%
-242M
92.79%
accounts receivables
869M
-
1.62B
86.19%
348M
78.49%
-1.35B
489.37%
327M
124.13%
inventory
-1.18B
-
-3.60B
204.13%
-1.10B
69.44%
-1.06B
3.91%
-1.03B
2.74%
-727M
29.28%
-280M
61.49%
-2.17B
674.29%
-2.70B
24.58%
200M
107.40%
accounts payables
-1.22B
-
-699M
42.66%
580M
182.98%
871M
50.17%
-984M
212.97%
other working capital
-283.20M
-
200M
170.62%
200M
0%
-522M
361%
other non cash items
-1.89B
-
-297M
84.26%
-400M
34.68%
-2.20B
450%
-276M
87.45%
-133M
51.81%
-122M
8.27%
-434M
255.74%
-780M
79.72%
-432M
44.62%
-1.75B
304.40%
net cash provided by operating activities
3.84B
-
4.84B
26.13%
3.20B
33.87%
6.50B
103.13%
7.02B
7.95%
6.00B
14.46%
8.26B
37.62%
6.83B
17.37%
5.37B
21.26%
5.52B
2.72%
6.22B
12.77%
investments in property plant and equipment
-2.03B
-
-2.42B
19.12%
-2.80B
15.83%
-2.60B
7.14%
-8.23B
216.46%
-3.58B
56.45%
-2.69B
24.92%
-3.43B
27.55%
-2.70B
21.39%
-3.18B
17.95%
-5.54B
74.00%
acquisitions net
-19.76B
-
-2.23B
88.72%
-700M
68.61%
-9.50B
1,257.14%
-152M
98.40%
12.30B
8,191.45%
3.95B
67.92%
12.77B
223.57%
73M
99.43%
317M
334.25%
-911M
387.38%
purchases of investments
-54.60M
-
-1.30B
-
-389M
70.05%
-740M
90.23%
-469M
36.62%
sales maturities of investments
3.05B
-
1.30B
-
389M
70.05%
740M
90.23%
90M
87.84%
other investing activites
943.10M
-
89.90M
90.47%
3.50B
3,793.21%
400M
88.57%
-4.43B
1,208.25%
-5.48B
23.57%
368M
106.72%
426M
15.76%
842M
97.65%
-557M
166.15%
-3.97B
613.29%
net cash used for investing activites
-20.85B
-
-1.56B
92.51%
1.10B
170.47%
-11.70B
1,163.64%
-12.81B
9.51%
3.24B
125.27%
1.62B
49.85%
9.76B
501.17%
-2.16B
122.13%
-3.42B
58.31%
-9.47B
176.76%
debt repayment
-14.18B
-
-48.70B
243.44%
-19B
60.99%
-11.50B
39.49%
-33.12B
188.13%
-25.48B
23.09%
-30.08B
18.06%
-15.66B
47.93%
-6.58B
57.95%
-5.41B
17.92%
common stock issued
2.70M
-
200K
92.59%
23.36B
-
17.52B
-
common stock repurchased
-22.30M
-
-22.70M
1.79%
-100M
340.53%
-44M
-
-29M
34.09%
-41M
41.38%
-50M
21.95%
-1.86B
3,614%
-136M
92.68%
-56M
58.82%
dividends paid
-716.20M
-
-857.70M
19.76%
-1B
16.59%
-1.20B
20%
-1.31B
9.42%
-1.44B
9.44%
-1.20B
-
-1.46B
21.66%
-1.52B
4.81%
other financing activites
20.18B
-
12.82B
36.49%
46.70B
264.32%
25.20B
46.04%
19.19B
23.87%
-41M
100.21%
14.05B
34,370.73%
14.48B
3.05%
-3.48B
124.03%
7.76B
322.87%
net cash used provided by financing activities
19.45B
-
-2.24B
111.53%
-3.10B
38.29%
5B
261.29%
6.33B
26.66%
-11.27B
277.88%
-11.46B
1.78%
-15.65B
36.48%
-4.68B
70.12%
-420M
91.02%
3.62B
962.62%
effect of forex changes on cash
312.20M
-
-338.90M
208.55%
-200M
40.99%
-500M
150%
389M
177.80%
59M
84.83%
1.05B
1,679.66%
-602M
157.33%
479M
179.57%
843M
75.99%
-653M
177.46%
net change in cash
2.75B
-
697.20M
74.61%
1B
43.43%
-700M
170%
926M
232.29%
-1.97B
312.31%
-531M
72.99%
338M
163.65%
-984M
391.12%
2.52B
356.30%
-273M
110.82%
cash at beginning of period
3.42B
-
6.16B
80.37%
6.90B
11.98%
7.90B
14.49%
7.19B
9.01%
8.11B
12.88%
6.15B
24.23%
5.62B
8.64%
5.96B
6.02%
4.97B
16.52%
7.49B
50.73%
cash at end of period
6.16B
-
6.86B
11.31%
7.90B
15.18%
7.20B
8.86%
8.11B
12.69%
6.15B
24.23%
5.62B
8.64%
5.96B
6.02%
4.97B
16.52%
7.49B
50.73%
7.22B
3.64%
operating cash flow
3.84B
-
4.84B
26.13%
3.20B
33.87%
6.50B
103.13%
7.02B
7.95%
6.00B
14.46%
8.26B
37.62%
6.83B
17.37%
5.37B
21.26%
5.52B
2.72%
6.22B
12.77%
capital expenditure
-2.03B
-
-2.42B
19.12%
-2.80B
15.83%
-2.60B
7.14%
-8.23B
216.46%
-3.58B
56.45%
-2.69B
24.92%
-3.43B
27.55%
-2.70B
21.39%
-3.18B
17.95%
-5.54B
74.00%
free cash flow
1.81B
-
2.42B
34.00%
400M
83.48%
3.90B
875%
-1.21B
131.05%
2.42B
299.75%
5.57B
130.26%
3.39B
39.07%
2.68B
21.13%
2.34B
12.63%
690M
70.50%

All numbers in (except ratios and percentages)